You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2025

Profile for Ukraine Patent: 108838


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Ukraine Patent: 108838

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free May 1, 2030 Salix APRISO mesalamine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Last updated: July 29, 2025

tailed Analysis of the Scope, Claims, and Patent Landscape for Ukraine Patent UA108838


Introduction

Ukraine’s patent UA108838 pertains to a pharmaceutical invention registered within the Ukrainian intellectual property system. This patent encompasses a specific formulation or method intended for medical application, reflecting the country’s ongoing efforts to protect novel pharmaceutical compounds and innovations. This analysis aims to delineate the scope and claims of UA108838, contextualize its position within the Ukrainian and global patent landscapes, and evaluate its strategic significance for pharmaceutical innovation and patent portfolio management.


Patent Overview and Technical Field

UA108838 was filed to secure exclusive rights over a pharmaceutical composition, potentially targeting a specific medical condition with a unique formulation or method of use. As with most drug patents, the invention likely involves a novel combination of known compounds, a new method of synthesis, or a specific delivery mechanism that enhances efficacy or safety.

The patent’s technical field likely relates to pharmaceuticals, specifically targeting indications such as chronic diseases, infectious conditions, or other therapeutic areas of interest in Ukraine and neighboring markets. The patent application’s filing date determines its priority and potential contribution to the patent landscape.


Claims Analysis

The core strength of UA108838 resides in its claims—the legal definitions of the invention’s scope. Claims in pharmaceutical patents generally fall into two categories: independent claims defining broad invention rights, and dependent claims adding specific limitations or embodiments.

Type and Breadth of Claims

  • Composition Claims: These probably cover a formulation comprising specific active ingredients combined with excipients or carriers. The claims may specify the precise weight ratios, pH conditions, or stabilization agents, enhancing the patent’s defensibility against generic competition.

  • Method of Use Claims: These may cover particular therapeutic methods, such as a novel treatment regimen, dosage schedules, or administration routes, broadening patent coverage beyond the composition alone.

  • Process Claims: If the patent includes a novel synthesis or manufacturing process, these claims secure rights over specific technological steps used in manufacturing.

  • Device or Delivery System Claims: If applicable, claims might also cover specific drug delivery devices or controlled-release systems.

Claim Limitations and Scope

In Ukrainian patent practice, the claims tend to be carefully drafted to balance breadth with specificity. Overly broad claims risk invalidation for lack of novelty or inventive step; overly narrow claims could enable competitors to circumvent the patent.

Given the typical approach in pharmaceutical patents, UA108838’s claims likely aim to cover a core innovative aspect—such as a particular active compound combination or administration method—while including narrower dependent claims to protect specific embodiments.


Patent Landscape Context

National and Regional Coverage

UA108838’s strategic value hinges on its regional applicability. Located in Ukraine, it provides exclusive protection within Ukrainian jurisdiction. However, pharmaceutical companies often seek broader international patent protection through regional or global filings, such as:

  • European Patent Convention (EPC): For protection across Europe.
  • Patent Cooperation Treaty (PCT): To pursue international patent rights across multiple jurisdictions.

From the Ukrainian perspective, the patent landscape reveals a focus on domestically relevant innovations, often aligned with the country’s healthcare priorities (e.g., infectious diseases, chronic illnesses).

Comparison with International Patents

Based on publicly available data, the invention may overlap with formulations or methods patented elsewhere—highlighting the importance of assessing the novelty and inventive step. If similar patents exist abroad, it could influence UA108838's enforceability or open avenues for licensing negotiations or patent challenges.

Patent Families and Related Applications

Investigating family members of UA108838 reveals whether the applicant has filed equivalent or related patents in other jurisdictions. International patent families strengthen market position and provide strategic barriers against competitors.


Legal Status and Enforcement

As of the latest update, UA108838 is granted and maintained, implying a legally enforceable patent. Monitoring for potential oppositions, challenges, or patent term adjustments remains critical for assessing its durability against patent validity threats.


Strategic Importance and Commercial Implications

Patent UA108838 signifies an effort by the patent holder to establish a protected niche within the Ukrainian pharmaceutical market. Its scope potentially covers innovative formulations or methods, offering competitive advantages. The patent’s strength depends on how well claims are crafted to prevent infringement design-around, and whether it aligns with evolving therapeutic standards and regulatory requirements.

Pharmaceutical companies must monitor potential patent expiry, licensing opportunities, or infringement risks—both domestically and internationally—to maximize commercial returns.


Conclusion

UA108838 embodies a strategic piece in Ukraine’s pharmaceutical patent landscape. Its scope, rooted in precise claims, solidifies market exclusivity for its inventive concept within Ukrainian jurisdiction. Ensuring comprehensive protection involves understanding its claim breadth, potential overlaps with international patents, and legal status. Companies targeting this space should assess patent similarities, challenge invalidity threats, and consider international coverage for broader market access.


Key Takeaways

  • Claim Precision is Key: The strength of UA108838 relies heavily on the clarity and scope of its claims, balancing broad coverage with novelty requirements.
  • Regional vs. Global Strategy: While protective in Ukraine, expanding protection through regional or international filings enhances market reach.
  • Patent Landscape Analysis: Similar patents abroad can influence the patent’s enforceability and may present challenges or licensing opportunities.
  • Legal Status Monitoring: Regular status checks are vital to safeguard the patent’s enforceability against oppositions or challenges.
  • Market Positioning: The patent reinforces exclusivity, enabling strategic positioning within Ukraine’s pharmaceutical market, especially in highly competitive or innovative segments.

FAQs

1. What is the typical scope of claims in Ukrainian pharmaceutical patents like UA108838?
Claims generally define the invention’s core—covering specific compositions, methods, or processes—with a focus on novelty and inventive step. They aim to be sufficiently broad to prevent competition but specific enough to withstand legal scrutiny.

2. How does UA108838 compare with international patents in the same therapeutic area?
Comparison requires examining published patent applications globally. If similar inventions exist, UA108838 may face challenges regarding novelty or inventive step, affecting its enforceability and licensing potential.

3. Can UA108838 be extended to regulatory exclusivity?
Patent protection complements regulatory exclusivity but does not replace it. The patent provides legal rights to prevent infringement, while regulatory exclusivity (e.g., data exclusivity) grants market exclusivity independently.

4. What are potential challenges to the validity of UA108838?
Challenges could include prior art disclosures, lack of inventive step, or claims deemed overly broad. Oppositions or invalidity suits can threaten its enforceability.

5. How can companies leverage UA108838 for strategic advantage?
By understanding its scope, firms can develop around claims, seek licensing agreements, or challenge its validity if prior art emerges, thus tailoring their market strategies accordingly.


References

[1] Ukrainian State Intellectual Property Service. Patent UA108838.

[2] European Patent Office. Patent Classification and Search Resources.

[3] World Intellectual Property Organization. Patent Cooperation Treaty (PCT) Global Database.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.